echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Under the normalization of centralized procurement, what changes have been made to the corporate strategy of "Fast Horses" in the consistency evaluation?

    Under the normalization of centralized procurement, what changes have been made to the corporate strategy of "Fast Horses" in the consistency evaluation?

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the CPM New Drug Research and Development Monitoring Database (cpm.


    Figure 1 Monthly trend of the number of over-comment approvals

    Data source: CPM database

    According to CPM database statistics, up to now, the number of over-rated generic drugs has reached 466 (in terms of generic name + dosage form), of which 46 have been over-rated for the first time since 2021.


    Among the 46 varieties reviewed for the first time this year, there are 2 large varieties that rank within the top 50 in terms of drug consumption in sample hospitals, 4 rank within 50 to 100, and 6 rank within 100 to 500, accounting for a total of About 1/4 (Figure 2).


    Figure 2 The ranking of the amount of drugs used in the sample hospitals for the first time this year

    Data source: CPM database

    Table 1 Varieties reviewed for the first time in 2021

    (Sales top 100 sample hospitals in 2020)

    Nowadays, the national centralized drug procurement work has entered normalization.


    Figure 3 Competition situation of over-rated enterprises

    Data source: CPM database

    Judging from the past national drug collection bidding varieties, it is possible for the over-evaluated companies to collect 2 companies to be included in the collection.


    Table 2 Many companies have been evaluated and have not yet been included in the national collection of varieties

    (Sales top 100 sample hospitals in 2020)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.